Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of a combined lower carbohydrate and Mediterranean diet on metabolic syndrome severity: protocol for a randomised controlled trial.

The British journal of nutrition·2026
Same author

Therapeutic Potentials of the Seaweed-Derived Compounds for Alzheimer's Disease.

Molecules (Basel, Switzerland)·2025
Same author

Dietary Micronutrient Intake During Pregnancy Is Suboptimal in a Group of Healthy Scottish Women, Irrespective of Maternal Body Mass Index.

Nutrients·2025
Same author

Sirtuin Proteins and Memory: A Promising Target in Alzheimer's Disease Therapy?

Nutrients·2024
Same author

Dietary Intakes of Long-Chain Polyunsaturated Fatty Acids and Impulsivity: Comparing Non-Restricted, Vegetarian, and Vegan Diets.

Nutrients·2024
Same author

Diagnosis to Delivery: A Randomized Clinical Trial of Postmeal Walking in Women with Gestational Diabetes.

Medicine and science in sports and exercise·2024

Related Experiment Video

Updated: Mar 21, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

651

Reversal effect of simvastatin on the decrease in cannabinoid receptor 1 density in 6-hydroxydopamine lesioned rat

Nikolce Mackovski1, Jinchi Liao2, Ruihui Weng2

  • 1Department of Neurology, The Third Affiliated Hospital of Sun-Sen University, Tianhe Road 600, Guangzhou, Guangdong 510630, People's Republic of China; Centre of Translational Neurosciences, School of Medicine, University of Wollongong, NSW, 2522, Australia; Illawarra Health and Medical Research Institute, NSW 2522, Australia.

Life Sciences
|May 8, 2016
PubMed
Summary

Simvastatin treatment reversed cannabinoid 1 (CB1) receptor downregulation in a rat model of Parkinson's disease (PD). This suggests CB1 receptors are a potential therapeutic target for PD, impacting motor and cognitive functions.

Keywords:
6-hydroxydopamineCannabinoid 1 receptorParkinson's diseaseSimvastatin[(3)H] SR141716A

More Related Videos

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
08:07

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats

Published on: August 24, 2016

9.7K
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
10:09

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

52.5K

Related Experiment Videos

Last Updated: Mar 21, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

651
Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
08:07

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats

Published on: August 24, 2016

9.7K
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
10:09

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

52.5K

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Cannabinoid 1 (CB1) receptors are linked to the dopaminergic system and cognitive functions.
  • Statins are explored for Parkinson's disease (PD) due to anti-inflammatory and neuroprotective properties.

Purpose of the Study:

  • To investigate the effect of simvastatin on CB1 receptor expression in a 6-hydroxydopamine (6-OHDA) induced rat model of PD.

Main Methods:

  • A rat model of PD was created using 6-OHDA injection.
  • Rats were pre-treated and post-treated with simvastatin (1 or 10mg/kg/day) or saline.
  • CB1 receptor density was measured using [(3)H] SR141716A binding autoradiography.

Main Results:

  • 6-OHDA induced significant CB1 receptor downregulation across multiple brain regions.
  • High-dose simvastatin (10mg/kg/day) ameliorated this downregulation in most examined areas.
  • Low-dose simvastatin (1mg/kg/day) partially reversed downregulation in the substantia nigra and hippocampus.

Conclusions:

  • CB1 receptor alterations are implicated in PD-related motor and cognitive deficits.
  • Simvastatin demonstrates a critical role in modulating CB1 receptors in PD.
  • CB1 receptors represent a promising therapeutic target for Parkinson's disease treatment.